From: Conventional fractionation should not be the standard of care for T2 glottic cancer
Factor | Subgroup | Number (%) | 5-year LC % (95% CI) | p value (log rank) |
---|---|---|---|---|
Sex | Male | 98 (88) | 84.8% (75.5–90.8) | 0.20 |
Female | 14 (13) | 70.0% (38.3–87.6) | ||
Age (years) | <65 | 58 (52) | 73.2% (59.9–82.9) | 0.003 |
≥65 | 54 (48) | 93.9% (82.3–98.0) | ||
Stage | 2a | 76 (68) | 88.8% (79.0–94.2) | 0.032 |
2b | 36 (32) | 70.8% (52.4–83.1) | ||
Haemoglobin (g/dl) | <13 | 42 (38) | 89.4% (74.2–95.9) | 0.46 |
≥13 | 60 (54) | 81.1% (68.3–89.1) | ||
Unknown | 10 (9) | Â | ||
Smoker | Current/ex <1 yr | 46 (41) | 79.0% (63.6–88.4) | 0.42 |
Ex ≥ 1 year/never | 64 (57) | 87.0% (75.6–93.3) | ||
Unknown | 2 (2) | Â | ||
Alcohol | Low/no alcohol | 69 (62) | 82.5% (70.6–89.9) | 0.41 |
Heavy/previous heavy | 29 (26) | 89.6% (71.0–96.5) | ||
Unknown | 14 (13) | Â |